Reuben Scott S, Ekman Evan F
Department of Anesthesiology, Baystate Medical Center, Springfield, MA 01199, USA.
Anesth Analg. 2007 Jul;105(1):228-32. doi: 10.1213/01.ane.0000265443.20919.c8.
Unrelieved postoperative pain may impair rehabilitation, delay recovery, and result in poor outcomes. Preventive multimodal analgesic techniques may improve long-term outcome after surgery.
We randomized 200 consecutive patients to receive acetaminophen 1000 mg and either celecoxib 400 mg or placebo 1-2 h before anterior cruciate ligament surgery. All patients received intraarticular analgesics and had an external cooling system applied to the operative knee. After discharge patients were instructed to take acetaminophen 1000 mg every 6 h and either celecoxib 200 mg every 12 h or matching placebo for the first 14 days postoperatively. All patients were enrolled in an accelerated rehabilitation program. Six months postoperatively, the level of activity was assessed, as was the presence of patellofemoral complications including: anterior knee pain, flexion contracture, quadriceps weakness, and complex regional pain syndrome.
More patients in the control group developed patellofemoral complications compared to the celecoxib group (P = 0.001) including anterior knee pain (14/96; 15%) vs (4/95; 1%), complex regional pain syndrome (7/96; 7%) vs (1/95; 1%), flexion contractures (9/96; 9%) vs (2/95; 2%), and scar tissue requiring re-arthroscopy (8/96; 8%) vs (2/95; 2%) respectively. More patients in the celecoxib group returned to a higher activity level (84% vs 65%) (P < 0.01), were able to participate at a more intense level (P < 0.02), and return to full sports activity (P < 0.05).
The administration of celecoxib as a component of a preventive multimodal analgesic technique for anterior cruciate ligament reconstruction reduces long-term patellofemoral complications and increases the likelihood of returning to a preinjury level of activity.
术后疼痛未缓解可能会妨碍康复、延迟恢复并导致不良后果。预防性多模式镇痛技术可能会改善手术后的长期预后。
我们将200例连续患者随机分组,在进行前交叉韧带手术前1 - 2小时给予对乙酰氨基酚1000毫克以及塞来昔布400毫克或安慰剂。所有患者均接受关节内镇痛药物治疗,并对手术膝关节应用外部冷却系统。出院后,指导患者在术后的前14天每6小时服用对乙酰氨基酚1000毫克,每12小时服用塞来昔布200毫克或匹配的安慰剂。所有患者均参加加速康复计划。术后6个月,评估活动水平以及髌股并发症的存在情况,包括:膝前疼痛、屈曲挛缩、股四头肌无力和复杂性区域疼痛综合征。
与塞来昔布组相比,对照组出现髌股并发症的患者更多(P = 0.001),包括膝前疼痛(14/96;15%)对(4/95;1%)、复杂性区域疼痛综合征(7/96;7%)对(1/95;1%)、屈曲挛缩(9/96;9%)对(2/95;2%)以及需要再次关节镜检查的瘢痕组织(8/96;8%)对(2/95;2%)。塞来昔布组更多患者恢复到更高的活动水平(84%对65%)(P < 0.01),能够以更高强度参与活动(P < 0.02),并恢复到完全的体育活动(P < 0.05)。
将塞来昔布作为前交叉韧带重建预防性多模式镇痛技术的一部分进行给药,可减少长期髌股并发症,并增加恢复到受伤前活动水平的可能性。